DiamiR Reports Validation of Two Families of Brain-Enriched microRNAs as Highly Promising Blood-Based Biomarkers of Mild Cognitive Impairment
02. Januar 2014 04:00 ET
|
DiamiR LLC
MONMOUTH JUNCTION, NJ--(Marketwired - January 02, 2014) - DiamiR, LLC, a molecular diagnostics company focused on the development and commercialization of innovative blood-based...